MAPK3 and melanoma: A previous study showed that FOXD3 expression is elevated following the targeted inhibition of the B-RAF-MEK (MAP/ERK kinase)-ERK (extracellular signal-regulated kinase) 1/2 pathway in mutant B-RAF melanoma cells.